BTXPRESS
Live / Registered — Registered and renewed (as of 09 Apr 2021)
What this means for you
Registered since 04 Jan 2011. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 04 Jan 2021).
Record
- Serial number
- 77825004
- Registration number
- 3901596
- Mark type
- Stylized text
- Filed
- 11 Sept 2009
- Published for opposition
- 23 Feb 2010
- Registered
- 04 Jan 2011
- Next maintenance due
- 04 Jan 2021
- Attorney of record
- Jeremy D. Bisdorf
Goods and services
- Class 001 — Chemicals: Assays and reagents for use in genetic research; Assays for research purposes; Chemical reagents for non-medical purposes; Chemical solutions and preparations consisting of pre-mixed reactants and reagents for scientific and research use in connection with amplification, analysis or labeling of nucleic acid; Reagents for scientific or medical research use
Owner
- Harvard Bioscience, Inc., Holliston, MA, US
- Harvard Bioscience, Inc., Holliston, MA, US
- Harvard Bioscience, Inc., Holliston, MA, US
Prior registrations
Prosecution history
- 12 Jan 2023 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 12 Jan 2023 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 12 Jan 2023 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 09 Apr 2021 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 09 Apr 2021 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 09 Apr 2021 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 09 Apr 2021 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 06 Jan 2021 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
- 28 Dec 2020 — TEAS SECTION 8 & 9 RECEIVED
- 04 Jan 2020 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 23 Jul 2019 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 23 Jul 2019 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 14 Feb 2018 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
- 07 Feb 2018 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
- 01 Feb 2016 — NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED